Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocyto...
Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
About this item
Full title
Author / Creator
Publisher
Turkey: Türk Hematoloji Derneği
Journal title
Language
English
Formats
Publication information
Publisher
Turkey: Türk Hematoloji Derneği
Subjects
More information
Scope and Contents
Contents
Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag. Antinuclear antibody (ANA) positivity can be seen at rates of up to 30% in ITP patients. Despite being widely used, more markers to predict the response to...
Alternative Titles
Full title
Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d1c6cefa7a9a41968b82b65bbd71644a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1c6cefa7a9a41968b82b65bbd71644a
Other Identifiers
ISSN
1300-7777
E-ISSN
1308-5263
DOI
10.4274/tjh.galenos.2021.2021.0183
